Inventor · disambiguated record
Lawrence R. Marcin
Also filed as: MARCIN LAWRENCE R · MARCIN Lawrence
16 granted patents·3 pending applications·103 citations·filing 2002–2025
91Inventor score
Files withBRISTOL MYERS SQUIBB CO13VALO HEALTH INC2BIOHAVEN THERAPEUTICS LTD1BRISTOL MEYERS SQUIBB CO1PARKER MICHAEL F1
Top patents by PatentIndex Score
19 records- 0191US7300936B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 27, 2007·46 cites·24 claims
- 0288US7786122B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 31, 2010·12 cites·1 claims
- 0386US7902218B2Substituted tetrahydroisoquinolines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 8, 2011·5 cites·7 claims
- 0483US7338974B2Macrocyclic diaminopropanes as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 4, 2008·6 cites·8 claims
- 0583US7105516B2Compounds for the treatment of premature ejaculationBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 12, 2006·15 cites·59 claims
- 0677US6777437B2Cyclopropylindole derivatives as selective serotonin reuptake inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 17, 2004·12 cites·36 claims
- 0776US8349880B2Bicyclic compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 8, 2013·4 cites·6 claims
- 0869US9738642B2Triazolopyridine ether derivatives and their use in neurological and pyschiatric disordersBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·1 cites·11 claims
- 0959US11639353B2Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted May 2, 2023·0 cites·14 claims
- 1058US7084178B2Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivativesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 1, 2006·2 cites·8 claims
- 1154US8350084B2Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide productionBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 8, 2013·0 cites·1 claims
- 1253US7772221B2Diaminopropane derived macrocycles as inhibitors of β amyloid productionBRISTOL MEYERS SQUIBB CO·Filed 2008·Granted Aug 10, 2010·0 cites·13 claims
- 1352US11014922B2Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 25, 2021·0 cites·12 claims
- 1451US2022213059A1Inhibiting usp19VALO HEALTH INC·Filed 2020·Application pending·0 cites
- 1549US2022204495A1Inhibiting trabidVALO HEALTH INC·Filed 2020·Application pending·0 cites
- 1648US2025228957A1Bifunctional degraders of galactose-deficient immunoglobulinsBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 1746US8513253B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsPARKER MICHAEL F·Filed 2010·Granted Aug 20, 2013·0 cites·3 claims
- 1837US10112944B2Heterocyclic compounds useful as inhibitors of TNFBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 30, 2018·0 cites·12 claims
- 1935US8604024B2Compounds for the reduction of beta-amyloid productionTHOMPSON III LORIN A·Filed 2012·Granted Dec 10, 2013·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →